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Background
Although the relation of Stevens-Johnson syndrome
(SJS) and Mycoplasma pneumoniae (MP) infection has
been well known, it remains unknown how MP infection
contributes to SJS development.
Method
We investigated the frequencies, phenotype and function
of Tregs in the peripheral blood of MP infection and
viral infections (measles virus, varicella-zoster virus, par-
vovirus B19, and EBV) patients at onset and after clinical
resolution, and healthy controls. The cytokine production
from CD4+ T cells stimulated with PMA/ionomycin and
Toll-like 2 and 4 specific cytokine productions from
monocytes was measured by FACS. Treg suppressive
function was measured by 3H-thymidine incorporation.
Results
During the acute stage of MP and viral infections, the
functional activity of Tregs to suppress T cell prolifera-
tion was profoundly impaired, although frequencies of
CD25++Foxp3+ Tregs in CD4+ T cells from patients of
MP, varicella-zoster virus, and parvovirus B19 infections
were not significantly altered. Upon resolution, however,
the impaired functional activity of Tregs was restored in
viral infections. In contrast, abrogation of Treg function
lasted 3 months to a year after MP infection.
Next, we investigated phenotype of Tregs in patients
of MP infection. A recent study has indicated that
Foxp3+CD4+ T cells can be classified into functionally
distinct subpopulations based on CD45RA and
Foxp3 expression: CD45RA+Foxp3+ natural Tregs,
CD45RAFoxp3++ induced Tregs, and CD45RAFoxp3+
nonsuppressive T cells. Although expression level of
CTLA-4, CD127, and CD39 on Foxp3+CD4+ T cells
did not change compared with controls, the percentage
of CD45RAFoxp3+ in Foxp3+CD4+ T cells was signifi-
cantly increased in the resolution stage of MP infec-
tion. The percentage of Th1 and Th2 but not Th17
was significantly increased during the resolution stage
of MP infection.
Our recent study has reported that monocytes can
control peripheral Treg development. Both of IL-6 and
IL-10 production from CD14+ monocytes upon TLR-2
but not TLR-4 stimulation was significantly increased
during the resolution stage of MP infection. These
results suggest that the unique cytokine profile of
monocytes upon TLR2 stimulation might be associated
with induction CD45RAFoxp3+ T cells.
Conclusion
Our findings suggest that MP infections could serve to
enhance the risk of subsequently developing severe aller-
gic diseases by chronically abrogating Treg-mediated
suppression.
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